Naples Global Advisors’s AbbVie ABBV Stock Holding History

Naples Global Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.1M	Buy	48,122 +406	+0.9%	+$87.3K	0.75%	33
2026 Q1	$10.4M	Sell	47,716 -40	-0.1%	-$8.87K	0.76%	31
2025 Q4	$10.9M	Sell	47,756 -581	-1%	-$132K	0.82%	22
2025 Q3	$11.2M	Buy	48,337 +1,068	+2%	+$217K	0.87%	18
2025 Q2	$8.77M	Sell	47,269 -369	-0.8%	-$68.6K	0.76%	27
2025 Q1	$9.98M	Sell	47,638 -1,135	-2%	-$221K	0.95%	16
2024 Q4	$8.67M	Sell	48,773 -169	-0.3%	-$31.1K	0.81%	20
2024 Q3	$9.67M	Sell	48,942 -456	-0.9%	-$85.1K	0.9%	18
2024 Q2	$8.47M	Sell	49,398 -132	-0.3%	-$21.9K	0.85%	19
2024 Q1	$9.02M	Sell	49,530 -576	-1%	-$99.3K	0.92%	16
2023 Q4	$7.76M	Sell	50,106 -1,478	-3%	-$215K	0.85%	18
2023 Q3	$7.69M	Sell	51,584 -717	-1%	-$105K	0.93%	17
2023 Q2	$7.05M	Sell	52,301 -318	-0.6%	-$46.6K	0.83%	20
2023 Q1	$8.39M	Sell	52,619 -346	-0.7%	-$52.9K	1.05%	12
2022 Q4	$8.56M	Sell	52,965 -303	-0.6%	-$46.5K	1.09%	10
2022 Q3	$7.15M	Buy	53,268 +698	+1%	+$100K	0.98%	15
2022 Q2	$8.05M	Buy	52,570 +934	+2%	+$143K	1.04%	11
2022 Q1	$8.37M	Sell	51,636 -95	-0.2%	-$13.8K	0.97%	13
2021 Q4	$7M	Buy	51,731 +410	+0.8%	+$48.4K	0.81%	22
2021 Q3	$5.54M	Buy	51,321 +2,053	+4%	+$235K	0.73%	29
2021 Q2	$5.55M	Buy	49,268 +2,290	+5%	+$258K	0.77%	27
2021 Q1	$5.08M	Buy	46,978 +998	+2%	+$107K	0.77%	28
2020 Q4	$4.93M	Buy	45,980 +2,657	+6%	+$255K	0.83%	22
2020 Q3	$3.79M	Buy	43,323 +832	+2%	+$78.3K	0.74%	30
2020 Q2	$4.17M	Buy	42,491 +1,123	+3%	+$98.9K	0.9%	19
2020 Q1	$3.15M	Buy	41,368 +2,219	+6%	+$189K	0.83%	23
2019 Q4	$3.47M	Buy	39,149 +1,578	+4%	+$131K	0.73%	31
2019 Q3	$2.85M	Buy	37,571 +2,886	+8%	+$198K	0.66%	40
2019 Q2	$2.52M	Buy	34,685 +2,454	+8%	+$193K	0.61%	45
2019 Q1	$2.6M	Buy	32,231 +2,636	+9%	+$216K	0.66%	41
2018 Q4	$2.61M	Buy	29,595 +523	+2%	+$46K	0.74%	34
2018 Q3	$2.75M	Sell	29,072 -3,829	-12%	-$363K	0.73%	34
2018 Q2	$3.05M	Buy	32,901 +1,014	+3%	+$99K	0.86%	25
2018 Q1	$3.02M	Sell	31,887 -251	-0.8%	-$27.6K	0.9%	21
2017 Q4	$3.11M	Buy	32,138 +1,159	+4%	+$109K	0.92%	17
2017 Q3	$2.75M	Buy	30,979 +957	+3%	+$72.8K	0.92%	17
2017 Q2	$2.18M	Buy	30,022 +187	+0.6%	+$12.6K	0.77%	27
2017 Q1	$1.94M	Buy	29,835 +322	+1%	+$20.2K	0.7%	33
2016 Q4	$1.85M	Sell	29,513 -114	-0.4%	-$6.96K	0.72%	31
2016 Q3	$1.87M	Buy	29,627 +1,460	+5%	+$94.5K	0.73%	26
2016 Q2	$1.74M	Sell	28,167 -439	-2%	-$26.8K	0.71%	27
2016 Q1	$1.63M	Buy	28,606 +1,178	+4%	+$65.7K	0.68%	29
2015 Q4	$1.63M	Buy	27,428 +309	+1%	+$17.8K	0.79%	26
2015 Q3	$1.48M	Buy	27,119 +1,420	+6%	+$92.4K	0.76%	27
2015 Q2	$1.73M	Buy	25,699 +17	+0.1%	+$1.11K	0.83%	17
2015 Q1	$1.5M	Buy	25,682 +2,205	+9%	+$133K	0.71%	25
2014 Q4	$1.54M	Buy	23,477 +739	+3%	+$46.6K	0.81%	19
2014 Q3	$1.31M	Buy	22,738 +368	+2%	+$20.4K	0.77%	23
2014 Q2	$1.26M	Buy	22,370 +1,053	+5%	+$55.2K	0.75%	23
2014 Q1	$1.1M	Buy	21,317 +2,377	+13%	+$120K	0.67%	31
2013 Q4	$1M	Buy	+18,940	New	+$931K	0.67%	32

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Naples Global Advisors's ABBV Position: Q2 2026 in Review

Naples Global Advisors increased its AbbVie (ABBV) stake by 0.85% in Q2 2026, buying an estimated $87.3K and bringing the position to 48,122 shares worth $12.1M. The position accounts for 0.75% of the portfolio, ranked #33.

Naples Global Advisors first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Naples Global Advisors held 48,122 shares of AbbVie worth $12.1M as of Q2 2026.
Naples Global Advisors bought 406 AbbVie shares in Q2 2026, an estimated $87.3K.
AbbVie made up 0.75% of Naples Global Advisors's portfolio in Q2 2026, its #33 holding.
Naples Global Advisors first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Naples Global Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.